Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation

Marti Pumarola Batlle, Carles Arus Caralto, Ana Paula Candiota Silveira, Milena Acosta González, Magdalena Ciezka, Cristina Herranz, Josep M. Canals

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)


The initial aim of this study was to generate a transplantable glial tumour model of low-intermediate grade by disaggregation of a spontaneous tumour mass from genetically engineered models (GEM). This should result in an increased tumour incidence in comparison to GEM animals. An anaplastic oligoastrocytoma (OA) tumour of World Health Organization (WHO) grade III was obtained from a female GEM mouse with the S100β-v-erbB/inK4a-Arf (+/−) genotype maintained in the C57BL/6 background. The tumour tissue was disaggregated; tumour cells from it were grown in aggregates and stereotactically injected into C57BL/6 mice. Tumour development was followed using Magnetic Resonance Imaging (MRI), while changes in the metabolomics pattern of the masses were evaluated by Magnetic Resonance Spectroscopy/Spectroscopic Imaging (MRS/MRSI). Final tumour grade was evaluated by histopathological analysis. The total number of tumours generated from GEM cells from disaggregated tumour (CDT) was 67 with up to 100 % penetrance, as compared to 16 % in the local GEM model, with an average survival time of 66 ± 55 days, up to 4.3-fold significantly higher than the standard GL261 glioblastoma (GBM) tumour model. Tumours produced by transplantation of cells freshly obtained from disaggregated GEM tumour were diagnosed as WHO grade III anaplastic oligodendroglioma (ODG) and OA, while tumours produced from a previously frozen sample were diagnosed as WHO grade IV GBM. We successfully grew CDT and generated tumours from a grade III GEM glial tumour. Freezing and cell culture protocols produced progression to grade IV GBM, which makes the developed transplantable model qualify as potential secondary GBM model in mice.

Original languageEnglish
Pages (from-to)67-76
Number of pages10
JournalJournal of Neuro-Oncology
Issue number1
Publication statusPublished - 1 Aug 2016


  • Disaggregated tumour
  • Molecular imaging
  • Preclinical brain tumour
  • Secondary glioblastoma


Dive into the research topics of 'Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation'. Together they form a unique fingerprint.

Cite this